A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Phase 3, Multicenter, Double-blind, Randomized Controlled Study Evaluating the Efficacy and Safety of Pegloticase Administered by Subcutaneous Injection Compared With Pegloticase Administered by Intravenous Injection, Both Administered Concurrently With Methotrexate Weekly, in Participants With Uncontrolled Gout
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: Amgen Call Center
- Phone Number: 866-572-6436
- Email: medinfo@amgen.com
Study Locations
-
-
-
San Juan, Puerto Rico, 00917
- Recruiting
- Caribbean Health Research Center
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Recruiting
- University of Alabama at Birmingham
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Orthopedic Physicians Alaska
-
-
California
-
Anaheim, California, United States, 92802
- Recruiting
- Precision Rheumatology
-
Chula Vista, California, United States, 91910
- Recruiting
- Advanced Clinical Research Center, LLC dba TriWest Research Associates
-
Tustin, California, United States, 92780
- Recruiting
- Solace Clinical Research
-
-
Colorado
-
Denver, Colorado, United States, 80230
- Recruiting
- Denver Arthritis Clinic PC
-
-
Florida
-
Aventura, Florida, United States, 33180
- Recruiting
- Arthritis and Rheumatic Disease Specialties
-
Aventura, Florida, United States, 33180
- Recruiting
- D and H Pompano Research Center
-
Bay Pines, Florida, United States, 33744
- Recruiting
- Bay Pines Veterans Affairs Healthcare System
-
Coral Springs, Florida, United States, 33065
- Recruiting
- Discovery Health Research Center
-
DeLand, Florida, United States, 32720
- Recruiting
- Hillcrest Medical Research
-
Hialeah, Florida, United States, 33016
- Recruiting
- New Generation Of Medical Research
-
Homestead, Florida, United States, 33033
- Recruiting
- Homestead Associates in Research Inc
-
Miami, Florida, United States, 33176
- Recruiting
- Entrust Clinical Research
-
Miami, Florida, United States, 33156
- Recruiting
- Advanced Clinical Research
-
Miami, Florida, United States, 33184
- Recruiting
- Felicidad Medical Research
-
Miami, Florida, United States, 33155
- Recruiting
- D and H National Research Centers
-
Miami, Florida, United States, 33126
- Recruiting
- Pharmax Research Clinic
-
Miami, Florida, United States, 33143
- Recruiting
- Well Pharma Medical Research Corp
-
Pinellas Park, Florida, United States, 33782
- Recruiting
- Decision Management International Research
-
Plantation, Florida, United States, 33324
- Recruiting
- Integral Rheumatology and Immunology Specialists
-
Tamarac, Florida, United States, 33321
- Recruiting
- D and H Tamarac Research Center
-
Tampa, Florida, United States, 33609
- Recruiting
- GCP Clinical Research, LLC
-
Tampa, Florida, United States, 33613
- Recruiting
- ClinPro Research Solutions LLC
-
Tampa, Florida, United States, 33607
- Recruiting
- Nodal Medical Center Research
-
Winter Park, Florida, United States, 32789
- Recruiting
- Conquest Research - Winter Park
-
-
Georgia
-
Marietta, Georgia, United States, 30066
- Recruiting
- Spatium Urgent Care
-
Newnan, Georgia, United States, 30265
- Recruiting
- Vista Clinical Research
-
-
Idaho
-
Boise, Idaho, United States, 83702
- Recruiting
- Saint Lukes Intermountain Research Center
-
-
Illinois
-
Chicago, Illinois, United States, 60640
- Recruiting
- Flourish Research Ravenswood
-
Chicago, Illinois, United States, 60618
- Recruiting
- Charter Research
-
Schaumburg, Illinois, United States, 60195
- Recruiting
- Greater Chicago Specialty Physicians
-
Willowbrook, Illinois, United States, 60527
- Recruiting
- Willow Rheumatology and Wellness
-
-
Louisiana
-
Mandeville, Louisiana, United States, 70471
- Recruiting
- Clinical Trials Management, LLC, d/b/a Flourish Research
-
-
Maryland
-
Columbia, Maryland, United States, 21045
- Recruiting
- Kur Research at Columbia Medical Practice
-
Oxon Hill, Maryland, United States, 20745
- Recruiting
- MD Medical Research
-
-
Michigan
-
Lansing, Michigan, United States, 48911
- Recruiting
- June DO PC
-
Saint Clair Shores, Michigan, United States, 48081
- Recruiting
- Clinical Research Institute of Michigan
-
Troy, Michigan, United States, 48085
- Recruiting
- Oakland Medical Research Center
-
-
New Jersey
-
Hamilton, New Jersey, United States, 08690
- Recruiting
- Bioluminux Clinical Research - Hamilton
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87108
- Recruiting
- Raymond G Murphy Veteran Affairs Medical Center
-
Santa Fe, New Mexico, United States, 87505
- Recruiting
- Inspire Santa Fe Medical Group
-
-
New York
-
Orchard Park, New York, United States, 14127
- Recruiting
- Buffalo Rheumatology and Medicine
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Recruiting
- Joint and Muscle Research Institute
-
Charlotte, North Carolina, United States, 28211
- Recruiting
- OnSite Clinical Solutions, LLC
-
Charlotte, North Carolina, United States, 28202
- Recruiting
- Arthritis and Osteoporosis Consultants of the Carolinas
-
Denver, North Carolina, United States, 28037
- Recruiting
- Research Carolina Elite
-
Greensboro, North Carolina, United States, 27410
- Recruiting
- Triad Clinical Trials, LLC
-
Leland, North Carolina, United States, 28451
- Recruiting
- Cape Fear Arthritis Care, PLLC
-
Salisbury, North Carolina, United States, 28144
- Recruiting
- Accellacare Salisbury
-
Shelby, North Carolina, United States, 28150
- Recruiting
- Shelby Clinical Research
-
Shelby, North Carolina, United States, 28150
- Recruiting
- Carolina Research Center Inc
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- Ohio State University Wexner Medical Center Clinical Research Center
-
Middleburg Heights, Ohio, United States, 44130
- Recruiting
- Paramount Medical Research and Consulting LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73111
- Recruiting
- Lynn Health Science Institute
-
-
Pennsylvania
-
Duncansville, Pennsylvania, United States, 16635
- Recruiting
- Altoona Center for Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, United States, 29486
- Recruiting
- Articularis Healthcare Group Inc dba Low Country Rheumatology
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57702
- Recruiting
- Health Concepts
-
-
Tennessee
-
Jackson, Tennessee, United States, 38305
- Recruiting
- West Tennessee Research Institute
-
-
Texas
-
Dallas, Texas, United States, 75230
- Recruiting
- Southwest Rheumatology
-
Houston, Texas, United States, 77089
- Recruiting
- Research Physicians Network, LLC
-
Houston, Texas, United States, 77099
- Recruiting
- Pioneer Research Solutions Inc
-
Katy, Texas, United States, 77494
- Recruiting
- Biopharma Informatic, LLC
-
Katy, Texas, United States, 77450
- Recruiting
- Texas Arthritis & Rheumatology Associates
-
Lewisville, Texas, United States, 75057
- Recruiting
- Epic Clinical Research
-
Round Rock, Texas, United States, 78681
- Recruiting
- Be Well Clinical Studies
-
Sugar Land, Texas, United States, 77479
- Recruiting
- Siena Research Network
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Recruiting
- Virginia Commonwealth University
-
-
Washington
-
Bellevue, Washington, United States, 98004
- Recruiting
- Overlake Arthritis and Osteoperosis Center
-
Spokane, Washington, United States, 99204
- Recruiting
- Arthritis Northwest Professional Limited Liability Company
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Participant has provided informed consent before initiation of any trial-specific activities/procedures.
- Age ≥ 18 years or ≥ legal age within the country if it is older than 18 years.
- Participants willing and able to comply with the prescribed treatment protocol and evaluations for the duration of the trial.
- Participants with uncontrolled gout, as meeting the protocol defined criteria.
Exclusion Criteria
- Glucose-6-phosphate dehydrogenase deficiency (tested at the screening visit).
- Liver transaminase levels (aspartate aminotransferase [AST] or alanine aminotransferase [ALT]) > 1.25 x upper limit of normal (ULN) or albumin < the lower limit of normal (LLN) at the screening visit.
- Uncontrolled diabetes mellitus and/or hemoglobin A1c (HbA1c) > 8%.
- Known intolerance to MTX.
- Participant received prior treatment with pegloticase, another recombinant uricase (ie, rasburicase or pegadricase), or concomitant therapy with a polyethylene glycol (PEG)-conjugated drug.
- A known intolerance to all protocol standard gout flare prophylaxis regimens (ie, participant must be able to tolerate at least 1 of the following: colchicine and/or non-steroidal anti-inflammatory drug and/or low-dose prednisone ≤ 10 mg/day or equivalent dose of other corticosteroid).
- Chronic renal impairment defined as estimated glomerular filtration rate (eGFR) based on Modification of Diet in Renal Disease (MDRD) calculations < 40 mL/min/1.73 m^2 or currently on dialysis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Pegloticase SC with MTX
Participants will receive pegloticase SC every two weeks with MTX.
|
Participants will receive pegloticase either SC or IV.
Other Names:
MTX will be administered orally.
Other Names:
|
|
Experimental: Pegloticase IV with MTX
Participants will receive pegloticase IV every two weeks with MTX.
|
Participants will receive pegloticase either SC or IV.
Other Names:
MTX will be administered orally.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Achieving Month 6 Response at Weeks 20, 21, 22, 23, and 24
Time Frame: Month 6 (Weeks 20, 21, 22, 23, and 24)
|
Defined as Achieving and Maintaining sUA < 6 mg/dL for at Least 80% of the Time During Month 6.
|
Month 6 (Weeks 20, 21, 22, 23, and 24)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of Participants With Serious Injection Site Reactions Through Week 48
Time Frame: Up to Week 48
|
Up to Week 48
|
|
Number of Participants With Serious Adjudicated Infusion Reactions (Including Adjudicated Anaphylaxis) Through Week 48
Time Frame: Up to Week 48
|
Up to Week 48
|
|
Number of Participants With Adjudicated Anaphylaxis Through Week 48
Time Frame: Up to Week 48
|
Up to Week 48
|
|
Serum Concentrations of Pegloticase Following SC and IV Administration
Time Frame: Up to Week 48
|
Up to Week 48
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: MD, Amgen
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20230219
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.